Fibroblast growth factor (FGF)-23 and hypophosphatemic rickets/osteomalacia

Endocrine Journal

Volumn 48, Issue 6, 2001, Pages 603-610

  Fukumoto, Seiji ^a   Yamashita, Takeyoshi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DENTIN MATRIX PROTEIN 1; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; PHOSPHATONIN; PHOSPHORUS; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; VITAMIN D;

AMINO TERMINAL SEQUENCE; AUTOSOMAL DOMINANT DISORDER; BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; CELL CULTURE; DNA LIBRARY; GENE MUTATION; GENE OVEREXPRESSION; HYPOPHOSPHATEMIA; MUSCLE WEAKNESS; OSTEOMALACIA; PARANEOPLASTIC SYNDROME; PATHOGENESIS; PATHOLOGIC FRACTURE; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; RICKETS; SEQUENCE HOMOLOGY; VITAMIN D METABOLISM; X CHROMOSOME LINKED DISORDER;

EID: 0035671261     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.48.603     Document Type: Review

References (34)

1. Tumor-induced rickets and osteomalacia
2. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia - A case report
3. Oncogenic osteomalacia: Lesion detection by MR skeletal survey
4. Tumor-induced osteomalacia- Unveiling a new hormone
5. Brief report: Inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia
6. Characteristics of tumor cell bioactivity in oncogenic osteomalacia
7. Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia
8. Oncogenic osteomalacia: Evidence for a humoral phosphaturic factor
9. Cellular/molecular control of renal Na/Pi-cotransport
10. Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine
11. +-phosphate cotransporter genes in murine kidney
12. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
13. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
14. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain
15. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia
16. The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting
17. Autosomal dominant hypophosphatemic rickets/osteomalacia: Clinical characterization of a novel renal phosphate-wasting disorder
18. FGF23 as a causative factor of hypophosphatemic diseases
19. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets
20. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX
21. Characterization of PHEX endopeptidase catalytic activity: Identification of parathyroid-hormonerelated peptide 107-139 as a substrate and osteocalcin, PPi and phosphate as inhibitors
22. Cloning of human PEX cDNA. Expression, subcellular localization, and endopeptidase activity
23. Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice
24. Pex mRNA is localized in developing mouse osteoblasts and odontoblasts
25. cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone
26. PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia
27. Tumor-induced osteomalacia and the regulation of phosphate homeostasis
28. The renal phosphate transport defect in normal mice parabiosed to X-linked hypophosphatemic mice persists after parathyroidectomy
29. Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect
30. Renal transplantation in hypophosphatemia with vitamin D-resistant rickets
31. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate
32. A survey of furin substrate specificity using substrate phage display
33. Fibroblast growth factors and their receptors
34. Metabolic studies in a patient with idiopathic hypophosphatemic osteomalacia